Australia - englanti - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - capecitabine -

Australia - englanti - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - capecitabine -

Australia - englanti - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - capecitabine, quantity: 150 mg - tablet, film coated - excipient ingredients: titanium dioxide; iron oxide red; macrogol 8000; magnesium stearate; lactose; colloidal anhydrous silica; methylcellulose; hypromellose; iron oxide yellow; hyprolose; croscarmellose sodium - colon cancer,capecitabine is indicated for the adjuvant treatment of patients with dukes' stage c and high-risk stage b, colon cancer, either as monotherapy or in combination with oxaliplatin.,colorectal cancer,capecitabine is indicated for the treatment of patients with advanced or metastatic colorectal cancer.,oesophagogastric cancer,capecitabine is indicated for the first-line treatment of patients with advanced oesophagogastric cancer in combination with a platinum-based regimen.,breast cancer,capecitabine is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of taxanes and an anthracycline containing chemotherapy regimen unless therapy with these and other standard agents are clinically contraindicated.,capecitabine in combination with docetaxel is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior anthracycline containing chemotherapy.

Irlanti - englanti - HPRA (Health Products Regulatory Authority)

fresenius kabi deutschland gmbh - capecitabine - film-coated tablet - 150 milligram(s) - pyrimidine analogues; capecitabine

Irlanti - englanti - HPRA (Health Products Regulatory Authority)

fresenius kabi deutschland gmbh - capecitabine - film-coated tablet - 500 milligram(s) - pyrimidine analogues; capecitabine

Uusi-Seelanti - englanti - Medsafe (Medicines Safety Authority)

viatris limited - capecitabine 150mg;  ;   - film coated tablet - 150 mg - active: capecitabine 150mg     excipient: croscarmellose sodium hypromellose   iron oxide red iron oxide yellow lactose magnesium stearate microcrystalline cellulose purified talc purified water titanium dioxide - capecitabine viatris tablets in combination with docetaxel is indicated for the treatment of patients with locally-advanced or metastatic breast cancer after failure of prior anthracycline-containing chemotherapy. capecitabine viatris tablets as monotherapy is indicated for the treatment of patients with locally-advanced or metastatic breast cancer after failure of both a taxane-containing and anthracycline-containing chemotherapy or in whom taxane-containing and anthracycline-containing therapy are not indicated.

Uusi-Seelanti - englanti - Medsafe (Medicines Safety Authority)

viatris limited - capecitabine 500mg;  ;   - film coated tablet - 500 mg - active: capecitabine 500mg     excipient: croscarmellose sodium hypromellose   iron oxide red iron oxide yellow lactose magnesium stearate microcrystalline cellulose purified talc purified water titanium dioxide - capecitabine viatris tablets in combination with docetaxel is indicated for the treatment of patients with locally-advanced or metastatic breast cancer after failure of prior anthracycline-containing chemotherapy. capecitabine viatris tablets as monotherapy is indicated for the treatment of patients with locally-advanced or metastatic breast cancer after failure of both a taxane-containing and anthracycline-containing chemotherapy or in whom taxane-containing and anthracycline-containing therapy are not indicated.

Belgia - englanti - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

actavis group ptc ehf - capecitabine 150 mg - film-coated tablet - 150 mg - capecitabine 150 mg - capecitabine

Belgia - englanti - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

actavis group ptc ehf - capecitabine 500 mg - film-coated tablet - 500 mg - capecitabine 500 mg - capecitabine

Belgia - englanti - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - capecitabine 150 mg - film-coated tablet - 150 mg - capecitabine 150 mg - capecitabine